6,268
Views
8
CrossRef citations to date
0
Altmetric
Research Paper

Effect of promoter, promoter mutation and enhancer on transgene expression mediated by episomal vectors in transfected HEK293, Chang liver and primary cells

, , , , , & ORCID Icon show all
Pages 548-560 | Received 19 Aug 2019, Accepted 16 Oct 2019, Published online: 31 Oct 2019

References

  • Wong SP, Argyros O, Harbottle RP. Sustained expression from DNA vectors. Adv Genet. 2015;89:113–152.
  • Xu Z, Chen F, Zhang L, et al. Non-integrating lentiviral vectors based on the minimal S/MAR sequence retain transgene expression in dividing cells. Sci China Life Sci. 2016;59(10):1024–1033.
  • Ehrhardt A, Haase R, Schepers A, et al. Episomal vectors for gene therapy. Curr Gene Ther. 2008;8(3):147–161.
  • Van Craenenbroeck K, Vanhoenacker P, Haegeman G. Episomal vectors for gene expression in mammalian cells. Eur J Biochem. 2000;267(18):5665–5678.
  • Hagedorn C, Wong SP, Harbottle R, et al. Scaffold/matrix attached region-based nonviral episomal vectors. Hum Gene Ther. 2011;22(8):915–923.
  • Su RJ, Neises A, Zhang XB. Generation of iPS cells from human peripheral blood mononuclear cells using episomal vectors. Methods Mol Biol. 2016;1357:57–69.
  • Piechaczek C, Fetzer C, Baiker A, et al. A vector based on the SV40 origin of replication and chromosomal S/MARs replicates episomally in CHO cells. Nucleic Acids Res. 1999;27:426–428.
  • Papapetrou EP, Ziros PG, Micheva ID, et al. Gene transfer into human hematopoietic progenitor cells with an episomal vector carryingan S/MAR element. Gene Ther. 2006;13(1):40–51.
  • Calado SM, Oliveira AV, Machado S, et al. Sustained gene expression in the retina by improved episomal vectors. Tissue Eng Part A. 2014;20(19–20):2692–2698.
  • Haase R, Magnusson T, Su B, et al. Generation of a tumor- and tissue-specific episomal non-viral vector system. BMC Biotechnol. 2013;13:49.
  • Klausner EA, Zhang Z, Wong SP, et al. Corneal gene delivery: chitosan oligomer as a carrier of CpG rich, CpG free or S/MAR plasmid DNA. J Gene Med. 2012;14(2):100–108.
  • Stehle IM, Scinteie MF, Baiker A, et al. Exploiting a minimal system to study the epigenetic control of DNA replication: the interplay between ranscription and replication. Chromosome Res. 2003;11(5):413–421.
  • Lin Y, Li Z, Wang T, et al. MAR characteristic motifs mediate episomal vector in CHO cells. Gene. 2015;559(2):137–143.
  • Zhang X, Wang XY, Jia YL, et al. A vector based on the chicken hypersensitive site 4 insulator element replicates episomally in mammalian cells. Curr Gene Ther. 2017;16(6):410–418.
  • Hagedorn C, Antoniou MN, Lipps HJ. Genomic cis- acting Sequences improve expression and establishment of a nonviral vector. Mol Ther Nucleic Acids. 2013;2(8):e118.
  • Moritz B, Becker PB, Göpfert U. CMV promoter mutants with a reduced propensity to productivity loss in CHO cells. Sci Rep. 2015;5:16952.
  • Hsu CC, Li HP, Hung YH, et al. Targeted methylation of CMV and E1A viral promoters. Biochem Biophys Res Comm. 2010;402(2):228–234.
  • Osterlehner A, Simmeth S, Göpfert U. Promoter methylation and transgene copy numbers predict unstable protein production in recombinant Chinese hamster ovary cell lines. Biotechnol Bioeng. 2011;108(11):2670–2681.
  • Running Deer J, Allison DS. High-level expression of proteins in mammalian cells using transcription regulatory sequences from the Chinese hamster EF-1alpha gene. Biotechnol Prog. 2004;20(3):880–889.
  • Ho SC, Yeo JH, Fang SG, et al. Impact of using different promoters and matrix attachment regions on recombinant protein expression level and stability in stably transfected CHO cells. Mol Biotechnol. 2015;57(2):138–144.
  • Wang X, Xu Z, Tian Z, et al. The EF-1a promoter maintains high-level transgene expression from episomal vectors in transfected CHO-K1 cells. J Cell Mol Med. 2017;21(11):3044–3054.
  • Brown AJ, Sweeney B, Mainwaring DO, et al. Synthetic promoters for CHO cell engineerin. Biotechnol Bioeng. 2014;111(8):1638–1647.
  • Quandt K, Frech K, Karas H, et al. New fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 1995;23(23):4878–4884.
  • Kuznetsov VA. Mathematical modeling of avidity distribution and estimating general binding properties of transcription factors from genome-wide binding profiles. Methods Mol Biol. 2017;1613:193–276.
  • Zamanighomi M, Lin Z, Wang Y, et al. Predicting transcription factor binding motifs from DNA-binding domains, chromatin accessibility and gene expression data. Nucleic Acids Res. 2017;45(10):5666–5677.
  • Norrman K, Fischer Y, Bonnamy B, et al. Quantitative comparison of constitutive promoters in human ES cells. PLoS One. 2010;5(8):e12413.
  • Ackford JG, Corredor JC, Pei Y, et al. Foreign gene expression and induction of antibody response by recombinant fowl adenovirus-9-based vectors with exogenous promoters. Vaccine. 2017;35(37):4974–4982.
  • Suzuki JI, Dezawa M, Kitada M. Prolonged but non-permanent expression of a transgene in ependymal cells of adult rats using an adenovirus-mediated transposon gene transfer system. Brain Res. 2017;1675:20–27.
  • Kurosaki F, Uchibori R, Mato N, et al. Optimization of adeno-associated virus vector-mediated gene transfer to the respiratory tract. Gene Ther. 2017;24(5):290–297.
  • Byun HM, Suh D, Jeong Y, et al. Plasmid vectors harboring cellular promoters can induce prolonged gene expression in hematopoietic and mesenchymal progenitor cells. Biochem Biophys Res Commun. 2005;332(2):518–523.
  • Gill DR, Smyth SE, Goddard CA, et al. Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter. Gene Ther. 2001;8(20):1539–1546.
  • Yang CQ, Li XY, Li Q, et al. Evaluation of three different promoters driving gene expression in developing chicken embryo by using in vivo electroporation. Genet Mol Res. 2014;13(1):1270–1277.
  • Liu Y, Fu S, Niu R, et al. Transcriptional activity assessment of three different promoters for mouse in utero electroporation system. Plasmid. 2014;74:52–58.
  • Luo Y, Liu C, Cerbini T, et al. Stable enhanced green fluorescent protein expression after differentiation and transplantation of reporter human induced pluripotent stem cells generated by AAVS1 transcription activator-like effector nucleases. Stem Cells Transl Med. 2014;3(7):821–835.
  • Chan KK, Wu SM, Nissom PM, et al. Generation of high-level stable transgene expressing human embryonic stem cell lines using Chinese hamster elongation factor-1 alpha promoter system. Stem Cells Dev. 2008;17(4):825–836.
  • Wang XY, Zhang JH, Zhang X, et al. Impact of different promoters on episomal vectors harbouring characteristic motifs of matrix attachment regions. Sci Rep. 2016;6:26446.
  • Yang Y, Chusainow J, Yap MG. DNA methylation contributes to loss in productivity of monoclonal antibody-producing CHO cell lines. J Biotechnol. 2010;147(3–4):180–185.
  • Wen S, Zhang H, Li Y, et al. Characterization of constitutive promoters for piggyBac transposon-mediated stable transgene expression in mesenchymal stem cells (MSCs). PLoS One. 2014;9:e94397.
  • Wang W, Jia YL, Li YC, et al. Impact of different promoters, promoter mutation, and an enhancer on recombinant protein expression in CHO cells. Sci Rep. 2017;7:10416.
  • Zhang XB. Cellular reprogramming of human peripheral blood cells. Genomics Proteomics Bioinformatics. 2013;11(5):264–274.
  • Han NR, Lee H, Baek S, et al. Delivery of episomal vectors into primary cells by means of commercial transfection reagents. Biochem Biophys Res Commun. 2015;461(2):348–353.
  • Stavrou EF, Lazaris VM, Giannakopoulos A, et al. The ß-globin replicator greatly enhances the potential of S/MAR based episomal vectors for gene transfer into human haematopoietic progenitor cells. Sci Rep. 2017;7:40673.